NOVA PHARMACEUTICAL INC
10QSB, EX-27, 2000-08-16
PHARMACEUTICAL PREPARATIONS
Previous: NOVA PHARMACEUTICAL INC, 10QSB, 2000-08-16
Next: DIGITAL BRIDGE INC, DEF 14C, 2000-08-16



<TABLE> <S> <C>

<ARTICLE>   5

    <S>                                             <C>
<PERIOD-TYPE>                                       6-MOS
<FISCAL-YEAR-END>                                DEC-31-2000
<PERIOD-END>                                     JUN-30-2000
<CASH>                                              4,220
<SECURITIES>                                            0
<RECEIVABLES>                                      15,000
<ALLOWANCES>                                            0
<INVENTORY>                                       130,596
<CURRENT-ASSETS>                                  771,081
<PP&E>                                             40,532
<DEPRECIATION>                                          0
<TOTAL-ASSETS>                                  1,665,756
<CURRENT-LIABILITIES>                           1,105,817
<BONDS>                                                 0
<COMMON>                                           17,732
                                   0
                                             0
<OTHER-SE>                                        466,492
<TOTAL-LIABILITY-AND-EQUITY>                    1,665,756
<SALES>                                           149,663
<TOTAL-REVENUES>                                  149,663
<CGS>                                              83,102
<TOTAL-COSTS>                                      83,102
<OTHER-EXPENSES>                                2,640,922
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                656,321
<INCOME-PRETAX>                                (3,891,802)
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                            (3,891,802)
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                   (3,891,802)
<EPS-BASIC>                                        (.25)
<EPS-DILUTED>                                        (.25)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission